SCHEMBL6411212

SCHEMBL6411212

COC(=O)C1C(COC(c2ccccc2)(c2ccccc2)c2ccccc2)C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KCNN4 O15554 1/20 0.38
ATM Q13315 1/20 0.37
KIF11 P52732 1/20 0.35
POLB P06746 1/20 0.34
ELANE P08246 1/20 0.34
SLC6A1 P30531 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP2C19 P33261 2/20 0.33
SLC6A11 P48066 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6412669 0.93 SLC6A11 (0.43) HTTALDH1A1LMNAHSD17B10KIF11
SCHEMBL6407236 0.93 SLC6A11 (0.43) HTTALDH1A1LMNAHSD17B10KIF11
SCHEMBL6408280 0.87 SLC6A1 (0.38) HTTALDH1A1KCNN4KIF11ELANE
SCHEMBL6408302 0.86 MDM2 (0.42) HTTALDH1A1GAALMNAHSD17B10
SCHEMBL6408024 0.86 CYP2C19 (0.36) HTTKIF11ELANESLC6A1MEN1
SCHEMBL6532218 0.86 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10ATMSLC6A1
SCHEMBL6410838 0.84 FABP7 (0.41) LMNASLC6A1CYP2C19SLC6A11CYP2D6
SCHEMBL6408835 0.82 SLC6A11 (0.41) ALDH1A1LMNAHSD17B10KIF11SLC6A1
SCHEMBL6414843 0.82 SLC6A11 (0.41) ALDH1A1LMNAHSD17B10KIF11SLC6A1
SCHEMBL6407137 0.82 SLC6A1 (0.41) ALDH1A1HSD17B10KIF11SLC6A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 HTT 1851/4885ALDH1A1 601/4885GAA 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.